Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter October 19, 2023

A comparison of cannabidiol (CBD) concentrations in venous vs. fingertip-capillary blood

  • Drusus A. Johnson , Lewis J. James and Liam M. Heaney ORCID logo EMAIL logo

Corresponding author: Liam M. Heaney, School of Sport, Exercise and Health Sciences, Loughborough University, Epinal Way, Loughborough LE11 3TU, UK, Phone: +441509226424, E-mail:

  1. Research ethics: The study protocol was approved the local research ethics committee and complied with the World Medical Association Declaration of Helsinki regarding ethical conduct of research involving human subjects.

  2. Informed consent: Informed consent was obtained from all individuals included in this study.

  3. Author contributions: The authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Competing interests: The authors state no conflict of interest.

  5. Research funding: Drusus A. Johnson is a doctoral researcher funded by Bridge Farm Nurseries ltd. and Loughborough University. The funder played no role in the production of this manuscript.

  6. Data availability: The raw data can be obtained on request from the corresponding author.

References

1. Lo Faro, AF, Tini, A, Gottardi, J, Pichini, S, Carlier, J, Giorgetti, R, et al.. UHPLC-MS-MS determination of THC, CBD and their metabolites in whole blood of light cannabis smokers. J Anal Toxicol 2023;46:e256–61. https://doi.org/10.1093/jat/bkac081.Search in Google Scholar PubMed

2. EUR-Lex. EUR-Lex – 32017R1155 – EN [Online]. https://eur-lex.europa.eu/eli/reg_del/2017/1155/oj [Accessed 12 Sep 2023].Search in Google Scholar

3. Agricultural Marketing Service. Establishment of a Domestic Hemp Production Program [Online]. https://www.federalregister.gov/documents/2019/10/31/2019-23749/establishment-of-a-domestic-hemp-production-program [Accessed 12 Sep 2023].Search in Google Scholar

4. Sholler, DJ, Schoene, L, Spindle, TR. Therapeutic efficacy of cannabidiol (CBD): a review of the evidence from clinical trials and human laboratory studies. Curr Addict Rep 2020;7:405–12. https://doi.org/10.1007/s40429-020-00326-8.Search in Google Scholar PubMed PubMed Central

5. Brightfield Group. US CBD Market Industry Update Fall 2021 Report [Online]. https://content.brightfieldgroup.com/us-cbd-market-report [Accessed 15 Sep 2023].Search in Google Scholar

6. Ujváry, I, Hanuš, L. Human metabolites of cannabidiol: a review on their formation, biological activity, and relevance in therapy. Cannabis Cannabinoid Res 2016;1:90–101. https://doi.org/10.1089/can.2015.0012.Search in Google Scholar PubMed PubMed Central

7. Johnson, DA, Funnell, MP, Heaney, LM, Wheeler, PC, Cable, TG, Bailey, SJ, et al.. Cannabidiol (CBD)-Oil ingested as sublingual drops or within gelatin capsules shows similar pharmacokinetic profiles in healthy males. Cannabis Cannabinoid Res 2023 Sep 22. https://doi.org/10.1089/can.2023.0117 [Epub ahead of print].Search in Google Scholar PubMed

8. Stott, CG, White, L, Wright, S, Wilbraham, D, Guy, GW. A phase I study to assess the effect of food on the single dose bioavailability of the THC/CBD oromucosal spray. Eur J Clin Pharmacol 2013;69:825–34. https://doi.org/10.1007/s00228-012-1393-4.Search in Google Scholar PubMed

9. Millar, SA, Maguire, RF, Yates, AS, O’Sullivan, SE. Towards better delivery of cannabidiol (CBD). Pharmaceuticals 2020;13:219. https://doi.org/10.3390/ph13090219.Search in Google Scholar PubMed PubMed Central

10. Kevin, RC, Vogel, R, Doohan, P, Berger, M, Amminger, GP, McGregor, IS. A validated method for the simultaneous quantification of cannabidiol, Δ9‐tetrahydrocannabinol, and their metabolites in human plasma and application to plasma samples from an oral cannabidiol open‐label trial. Drug Test Anal 2021;13:614–27. https://doi.org/10.1002/dta.2947.Search in Google Scholar PubMed

11. Malaca, S, Gottardi, M, Pigliasco, F, Barco, S, Cafaro, A, Amadori, E, et al.. UHPLC-MS/MS analysis of cannabidiol and its metabolites in serum of patients with resistant epilepsy treated with CBD formulations. Pharmaceuticals 2021;14:630. https://doi.org/10.3390/ph14070630.Search in Google Scholar PubMed PubMed Central

12. Crippa, JAS, Zuardi, AW, Hallak, JEC, Miyazawa, B, Bernardo, SA, Donaduzzi, CM, et al.. Oral cannabidiol does not convert to Δ8-THC or Δ9-THC in humans: a pharmacokinetic study in healthy subjects. Cannabis Cannabinoid Res 2020;5:89–98. https://doi.org/10.1089/can.2019.0024.Search in Google Scholar PubMed PubMed Central

13. Harrell, FE, Davis, CE. A new distribution-free quantile estimator. Biometrika 1982;69:635–40. https://doi.org/10.1093/biomet/69.3.635.Search in Google Scholar

14. McCartney, D, Kevin, RC, Suraev, AS, Sahinovic, A, Doohan, PT, Bedoya-Pérez, MA, et al.. How long does a single oral dose of cannabidiol persist in plasma? Findings from three clinical trials. Drug Test Anal 2023;15:334–44. https://doi.org/10.1002/dta.3419.Search in Google Scholar PubMed

Received: 2023-08-23
Accepted: 2023-10-10
Published Online: 2023-10-19
Published in Print: 2024-03-25

© 2023 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 28.4.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2023-0928/html
Scroll to top button